Cargando…

Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer

BACKGROUND: Prostate cancer (PCa) is one of the most common tumors and the second leading cause of cancer-related death in men. The discovery of novel biomarkers for PCa diagnosis in the early stage, as well as discriminating aggressive PCa from non-aggressive PCa continue to pose a challenge. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ce, Liu, Guangming, Liu, Yehua, Yang, Zhanpo, Xin, Weiwei, Wang, Meng, Li, Yang, Yang, Lan, Mu, Hong, Zhou, Chunlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582260/ https://www.ncbi.nlm.nih.gov/pubmed/36276156 http://dx.doi.org/10.3389/fonc.2022.1004015

Ejemplares similares

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma
por: Yu, Runhong, et al.
Publicado: (2022)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

MicroRNA-940 as a Potential Serum Biomarker for Prostate Cancer
por: Rajendiran, Smrithi, et al.
Publicado: (2021)

Machine Learning-Based Radiomics Predicting Tumor Grades and Expression of Multiple Pathologic Biomarkers in Gliomas
por: Gao, Min, et al.
Publicado: (2020)

Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia
por: Chang, Li-Chun, et al.
Publicado: (2021)

Comparative Study of Monoexponential, Intravoxel Incoherent Motion, Kurtosis, and IVIM-Kurtosis Models for the Diagnosis and Aggressiveness Assessment of Prostate Cancer
por: Liu, Ying, et al.
Publicado: (2020)

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
por: Parra, Nestor Andres, et al.
Publicado: (2017)

Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy
por: Ouyang, Taohui, et al.
Publicado: (2021)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
por: Song, Yuxuan, et al.
Publicado: (2020)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer
por: Diao, Yanjun, et al.
Publicado: (2023)

Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth
por: Jung, Minsun, et al.
Publicado: (2022)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
por: Bertelli, Elena, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
por: Singh, Anshika N., et al.
Publicado: (2020)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling
por: Chai, Yanlan, et al.
Publicado: (2015)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

Proteomic Profiling of Serum Exosomes From Patients With Metastatic Gastric Cancer
por: Ding, Xiao-Qing, et al.
Publicado: (2020)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
por: Song, Jin, et al.
Publicado: (2021)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Whole-gland high-intensity focused ultrasound ablation and transurethral resection of the prostate in the patients with prostate cancer: A systematic review and meta-analysis
por: Pan, Yang, et al.
Publicado: (2022)

FCGR3A: A new biomarker with potential prognostic value for prostate cancer
por: Zha, Zeyu, et al.
Publicado: (2022)

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)

Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers
por: Luo, Hui, et al.
Publicado: (2022)

Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer
por: Sun, Zujun, et al.
Publicado: (2021)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

Automatic Prostate Gleason Grading Using Pyramid Semantic Parsing Network in Digital Histopathology
por: Qiu, Yali, et al.
Publicado: (2022)

miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker
por: Zhao, Huan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e7ess1k6kdcitaf2brv29i1m5o